# 260 Commercial Investments Inc. – FDA Inspection, Jun 7, 2017

Source: https://www.keypedia.com/records/fda_inspections/260-commercial-investments-inc/c952bcfc-1d07-4049-9c77-22ac45a720c5
Source feed: FDA_Inspections

> FDA inspection 1013110 of 260 Commercial Investments Inc., June 07, 2017. 5 citations under 21 CFR parts 110 and 123. Form 483 issued. 15 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1013110
- Company Name: 260 Commercial Investments Inc.
- Inspection Date: 2017-06-07
- Project Area: Foodborne Biological Hazards
- Product Type: Foods & Cosmetics
- Center: Foods & Cosmetics
- Office Name: New England District Office
- Citation Count: 5

## Related Documents

- [FDA Inspection 1330394 - 2026-08-21](https://www.keypedia.com/records/fda_inspections/260-commercial-investments-inc/b1ccce12-f0f1-44ae-8161-c8689c53f988)
- FDA Inspection 1295450 - 2026-06-15
- [FDA Inspection 1238016 - 2024-04-25](https://www.keypedia.com/records/fda_inspections/260-commercial-investments-inc/4f7d590b-3640-4430-93c2-7aa17a594cb2)
- [FDA Inspection 1177674 - 2022-08-10](https://www.keypedia.com/records/fda_inspections/260-commercial-investments-inc/6ae439b4-2741-473d-987e-c016d1f5ece1)
- [FDA Inspection 1110476 - 2019-11-13](https://www.keypedia.com/records/fda_inspections/260-commercial-investments-inc/52cf6739-b8e2-4f1e-a85f-a7ce5bb85a02)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/christopher-j-cruciotti/11522b0d-6e60-4157-917c-8d1e430c9db2)
- [Issuing Officer](https://www.keypedia.com/people/clinton-v-giustra/a5931dbd-5f69-4129-8925-9837528d8b04)
- Issuing Officer

Company: https://www.keypedia.com/companies/260-commercial-investments-inc/11ee909a-1f33-4151-aecc-fada448d7597

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144